How to detect disease progression in pulmonary arterial hypertension

Vachiéry J-L., Yerly P., Huez S.

Source: Eur Respir Rev 2012; 21: 40-47
Journal Issue: March 2012 - 21 (123)
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Vachiéry J-L., Yerly P., Huez S.. How to detect disease progression in pulmonary arterial hypertension. Eur Respir Rev 2012; 21: 40-47

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The study of risk in pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21:234-238
Year: 2012



The burden of pulmonary hypertension
Source: Annual Congress 2006 - The burden of pulmonary hypertension
Year: 2006


Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 40: 93-100
Year: 2012



Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007



Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Novel treatment for pulmonary vascular disease: lessons from pathophysiology
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006


Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Bosentan for sarcoidosis associated pulmonary arterial hypertension (BoSAPH) was effective in advanced parenchymal lung disease
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012



Severe pulmonary hypertension in lung disease: phenotypes and response to treatment
Source: Eur Respir J 2015; 46: 1378-1389
Year: 2015



Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012



Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012



Clinical characteristics, haemodynamics, and survival in patients with combined pulmonary fibrosis and emphysema and associated pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008

Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005


Pulmonary vascular gradient: A predictor of prognosis in pulmonary hypertension due to left heart disease
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012

Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

Newly diagnosed patients with chronic thromboembolic pulmonary hypertension and PASP<50 mmHg. Do they need pulmonary endarterectomy?
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005


Treatment of pulmonary hypertension in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=313
Year: 2006